Keytruda Counterfeit Leak 2026: Merck Shifts Responsibility to Hospitals

Now the global pharmaceutical landscape is grappling with a sophisticated black market that exploits the waste of life-saving treatments. In an official response to the Keytruda counterfeit leak 2026, MSD (the international subsidiary of Merck & Co) has clarified its position regarding the reuse of its medicinal packaging. First, the company stated that the responsibility […] The post Keytruda Counterfeit Leak 2026: Merck Shifts Responsibility to Hospitals first appeared on Business League .